14Jul
Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation
We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....
By:
Goodwin
Related
As the potential spread of coronavirus disease 2019 (COVID-19) in the United States becomes a very r...
Read More >
In Hensel Phelps Constr. Co. v. Superior Court, 257 Cal. Rptr. 3d 746 (Cal. Ct. App. 2020), the Cour...
Read More >
While the United States and California legal worlds remain (understandably) focused on issues arisin...
Read More >
On October 2, 2020, the SBA issued guidance under a procedural notice (the “Notice”) providing inf...
Read More >
The EU Foreign Direct Investment Regulation will be in full force from October 11, 2020. We expect i...
Read More >
In August 2018, Governor Northam signed Executive Order 16, which established the Inter-Agency Taskf...
Read More >